Mira1a Therapeutics, Inc.
Baltimore, United States · Founded 2020
- Website not added yet
- LinkedIn not added yet
- X not added yet
- Instagram not added yet
- Facebook not added yet
Mira1a Therapeutics, Inc was founded in 2020 by Paul Rivard, ESQ, Jude Uzonwanne, Chris Chapman, MD, Brad Kroenig, James McNulty, CPA, Hugh McColl III, Talhia Tuck, JD, Josh Silverman, Dave Vorhoff and Adam Kaplin, MD, PhD, and is based in Baltimore, United States.
Key facts
- Industry
- Pharmaceuticals
- Legal form
- Incorporated in Florida
- Listed
- Nasdaq · MIRA
About
Pharmaceutical Preparations; formerly Mira1a Therapeutics, Inc.; listed on Nasdaq as MIRA; filing with the SEC since 2022
Founders
Executive Officer
1500 Founder Rating
Executive Officer
1500 Founder Rating
Director
1500 Founder Rating
Director
1500 Founder Rating
Executive Officer
1500 Founder Rating
Director
1500 Founder Rating
Director
1500 Founder Rating
Director
1500 Founder Rating
Director
1500 Founder Rating
Executive Officer
1500 Founder Rating
In context
We hold 176 other pharmaceuticals companies founded in the 2020s. None has a closure on record yet. Of the 164 that report what they raised, the median is $2,999,993.
Counted across this directory, from founding and closing years in public records. Medians cover only companies whose closure is recorded; a company with no closure date may have quietly ceased without the record catching it.
Discussion
Log in to join the discussion and like comments.
Log In to Comment